busulfan has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jubert, C | 1 |
| De Berranger, E | 1 |
| Castelle, M | 1 |
| Dalle, JH | 1 |
| Ouachee-Chardin, M | 1 |
| Sevin, C | 1 |
| Yakoub-Agha, I | 1 |
| Brassier, A | 1 |
| Díaz, D | 1 |
| Del Pilar, C | 1 |
| Carretero, J | 1 |
| Alonso, JR | 1 |
| Weruaga, E | 1 |
| Aldenhoven, M | 1 |
| Jones, SA | 1 |
| Bonney, D | 1 |
| Borrill, RE | 1 |
| Coussons, M | 1 |
| Mercer, J | 1 |
| Bierings, MB | 1 |
| Versluys, B | 1 |
| van Hasselt, PM | 1 |
| Wijburg, FA | 1 |
| van der Ploeg, AT | 1 |
| Wynn, RF | 1 |
| Boelens, JJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Granulocyte Transfusions After Umbilical Cord Blood Transplant for Leukaemia: A Prospective, Non-randomised, Single-centre Study to Evaluate Safety and Immune Reconstitution[NCT05425043] | 20 participants (Anticipated) | Interventional | 2021-09-14 | Recruiting | |||
| Phase I/II Study Evaluating Safety and Efficacy of Autologous Hematopoietic Stem and Progenitor Cells Genetically Modified With IDUA Lentiviral Vector Encoding for the Human α-L-iduronidase Gene for the Treatment of Patients Affected by Mucopolysaccharido[NCT03488394] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2018-05-11 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for busulfan and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
[Inborn error of metabolism and allogenic hematopoietic cell transplantation: Guidelines from the SFGM-TC].
Topics: Busulfan; Hematopoietic Stem Cell Transplantation; Humans; Mucopolysaccharidoses; Neurodegenerative | 2023 |
Daily bone marrow cell transplantations for the management of fast neurodegenerative processes.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Cell Count; Mice, Inbred BALB C; Mice, Inbred C57BL; | 2019 |
Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
Topics: Acute Disease; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantat | 2015 |
Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
Topics: Acute Disease; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantat | 2015 |
Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
Topics: Acute Disease; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantat | 2015 |
Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
Topics: Acute Disease; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantat | 2015 |